 Vaxart Inc. NASDAQ: VXRT shares traded higher Tuesday after a study titled A Phase 2 Trial With an Oral Tableted Covid-19 Vaccine was posted to Clinicaltrials.gov. This may have inspired retail traders to buy the stock. 